Verified peer comparison
AbCellera Biologics vs Recursion Pharmaceuticals Financial Comparison
Direct answer
AbCellera Biologics and Recursion Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- AbCellera Biologics Revenue
- 75,128,000 USD
- Recursion Pharmaceuticals Revenue
- 74,681,000 USD
- AbCellera Biologics Operating income
- -217,103,000 USD
- Recursion Pharmaceuticals Operating income
- -648,132,000 USD